N-(2-chloro-6-fluorobenzyl)-2-(2,5-dioxo-4-phenyl-4-propylimidazolidin-1-yl)-N-methylacetamide

Catalog No. :
ACHBMI774
CAS No. :
852935-07-0
Molecular Formula :
C22H23ClFN3O3
Molecular Weight :
431.89

IUPAC Name:N-(2-chloro-6-fluorobenzyl)-2-(2,5-dioxo-4-phenyl-4-propylimidazolidin-1-yl)-N-methylacetamide

N-(2-chloro-6-fluorobenzyl)-2-(2,5-dioxo-4-phenyl-4-propylimidazolidin-1-yl)-N-methylacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-chloro-6-fluorobenzyl)-2-(2,5-dioxo-4-phenyl-4-propylimidazolidin-1-yl)-N-methylacetamide
IUPAC NameN-(2-chloro-6-fluorobenzyl)-2-(2,5-dioxo-4-phenyl-4-propylimidazolidin-1-yl)-N-methylacetamide
MDL No.MFCD08702744
Molecular FormulaC22H23ClFN3O3
Molecular Weight431.89
SMILESCCCC1(C2=CC=CC=C2)NC(=O)N(CC(=O)N(C)CC2=C(F)C=CC=C2Cl)C1=O
InChI KeyLYOOCPLGHJKLEG-UHFFFAOYSA-N
SynonymCID-4785700;N-[(2-Chloro-6-fluorophenyl)methyl]-N-methyl-2,5-dioxo-4-phenyl-4-propyl-1-imidazolidineacetamide;1-Imidazolidineacetamide, N-[(2-chloro-6-fluorophenyl)methyl]-N-methyl-2,5-dioxo-4-phenyl-4-propyl-;N-[(2-Chloro-6-fluorophenyl)methyl]-2-(2,5-dioxo-4-phenyl-4-propylimidazolidin-1-yl)-N-methylacetamide
CAS No.852935-07-0

Synthetic Route by SureRoute

1. ACHBMI774 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHBMI774 route product structure diagram
    ACHBMI774852935-07-0
Inquiry

2. ACHBMI774 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHBMI774 route product structure diagram
    ACHBMI774852935-07-0
Inquiry

Comments (0)